Harvard Bioscience, Inc. (HBIO) Volatility Skew

Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.

Harvard Bioscience, Inc. (HBIO) operates in the Healthcare sector, specifically the Medical - Instruments & Supplies industry, with a market capitalization near $37.1M, listed on NASDAQ, employing roughly 328 people, carrying a beta of 1.51 to the broader market. Harvard Bioscience, Inc. Led by John D. Duke, public since 2000-12-07.

Volatility skew analysis compares implied volatility across strikes and expirations. No recent options activity for HBIO as of 2026-10-15; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how volatility skew is reported and how to read the data →